Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Oncology Network Inc. (AONC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/13/2025: AONC (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 37.63% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 387.54M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 |
52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.89 |
Earnings Date
Report Date 2025-06-27 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 534565887 | Price to Sales(TTM) 0.22 |
Enterprise Value 534565887 | Price to Sales(TTM) 0.22 | ||
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA 294.53 | Shares Outstanding 29248400 | Shares Floating 8989380 |
Shares Outstanding 29248400 | Shares Floating 8989380 | ||
Percent Insiders 77.99 | Percent Institutions 0.08 |
Upturn AI SWOT
American Oncology Network Inc.
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. It is a physician-led, community-based oncology network. AON aims to provide integrated, community-based cancer care.
Core Business Areas
- Community Oncology Practices: AON partners with and supports independent community oncology practices across the US. This includes providing resources, technology, and administrative support.
- Integrated Services: AON provides an integrated suite of services that includes clinical trials, pharmacy services, and payer strategies to improve patient outcomes and practice efficiency.
Leadership and Structure
Dr. Stephen Orman is the Chief Medical Officer and co-founder. Bradley Prechtl is the Chief Executive Officer and co-founder. The company structure is centered around physician partnerships and a management team providing support services.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides various practice management services that include revenue cycle management, HR, compliance, and technology infrastructure for community oncology practices. Market share is difficult to determine due to fragmentation. Competitors include McKesson, Cardinal Health, and AmerisourceBergen, which offer similar services.
- Clinical Trial Support: AON assists its partner practices in running clinical trials. Specific revenue data is not publicly available. Competitors include contract research organizations (CROs) such as IQVIA and PPD.
- Pharmacy Services: AON provides pharmacy services to partner practices including specialty drug access and management. The market share is difficult to determine due to fragmentation. Competitors include major pharmacy chains and specialty pharmacies.
Market Dynamics
Industry Overview
The oncology market is characterized by increasing cancer incidence, advancements in treatment options (e.g., immunotherapy, targeted therapies), and growing demand for community-based cancer care. The healthcare industry is undergoing significant consolidation and shifts in reimbursement models, with a growing emphasis on value-based care.
Positioning
AON positions itself as a leader in community-based oncology care, offering a platform for independent practices to thrive in a challenging environment. Its competitive advantage lies in its integrated service model, physician partnership approach, and focus on value-based care.
Total Addressable Market (TAM)
The US cancer care market is estimated to be hundreds of billions of dollars annually. AON is positioned to capture a portion of this TAM by partnering with and supporting community oncology practices. AON is well-positioned to grow with increasing market demand.
Upturn SWOT Analysis
Strengths
- Physician-led model
- Integrated service offerings
- Strong network of community practices
- Focus on value-based care
- Technology platform for improved efficiency
Weaknesses
- Reliance on partnerships with independent practices
- Potential challenges in scaling operations
- Competition from larger healthcare organizations
- Limited brand recognition compared to larger players
Opportunities
- Expansion into new geographic markets
- Development of new service offerings
- Increased adoption of value-based care models
- Further consolidation of community oncology practices
- Leveraging technology for enhanced patient care
Threats
- Changes in healthcare regulations and reimbursement policies
- Increased competition from other oncology networks and healthcare systems
- Economic downturn impacting patient access to care
- Rising drug costs and payer pressure
- Cybersecurity risks and data breaches
Competitors and Market Share
Key Competitors
- McKesson (MCK)
- Cardinal Health (CAH)
- AmerisourceBergen (COR)
Competitive Landscape
AON's advantage lies in its physician-led model and focus on community oncology. Disadvantages include smaller size and brand recognition compared to larger competitors like McKesson, Cardinal Health, and AmerisourceBergen.
Growth Trajectory and Initiatives
Historical Growth: American Oncology Network Inc. has experienced significant growth in its number of partner practices since its founding. Due to limited public information, specific historical growth rates are unavailable.
Future Projections: Future projections are uncertain due to the lack of publicly available information on AON's financials. However, the company's strategy of partnering with community oncology practices positions it for continued growth in a consolidating market.
Recent Initiatives: Recent initiatives include expanding its network of partner practices, enhancing its technology platform, and focusing on value-based care initiatives.
Summary
American Oncology Network (AON) is a growing physician-led oncology network that aims to support community practices. They face competition from larger healthcare companies, but have a unique value proposition. The growth of the company will rely on its successful partnerships with independent practices. One thing to look out for would be increased competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- American Oncology Network Inc. Website
- Company Press Releases
- Industry Reports
- Competitor SEC Filings
Disclaimers:
The information provided is based on publicly available data and may not be entirely comprehensive. Financial data is estimated. The AI-based rating is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc.
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-05 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.